TrialMolecular and cellular biochemistry2008

CIGB-300, a novel proapoptotic peptide that impairs the CK2 phosphorylation and exhibits anticancer properties both in vitro and in vivo.

Silvio E Perea et al.PubMed ↗Publisher ↗

No numbers read from the abstract.